引用本文:李 颖,尹良伟,刘基巍,刘 鹏.多西他赛对乳腺癌细胞中Cav-1表达及细胞增殖的影响[J].大连医科大学学报,2017,39(4):318-322.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 次   下载 本文二维码信息
码上扫一扫!
分享到: 微信 更多
多西他赛对乳腺癌细胞中Cav-1表达及细胞增殖的影响
李 颖1, 尹良伟2, 刘基巍1, 刘 鹏2
1.大连医科大学附属第一医院 肿瘤一科, 辽宁 大连 116011;2.大连医科大学附属大连市中心医院 肿瘤内科三病房, 辽宁 大连 116021
摘要:
目的 研究多西他赛对乳腺癌细胞中Cav-1(Cav-1)表达及细胞增殖的影响。方法 通过Real-time PCR和Western-blot检测不同浓度多西他赛作用下乳腺癌细胞MCF-7中Cav-1的表达情况;野生型MCF-7细胞株为对照组,通过基因转染技术建立Cav-1 过表达的MCF-7细胞株(转染组)及空载体的MCF-7细胞株(空载体组),利用CCK-8比色法分析多西他赛对各组细胞增殖的影响。通过Western-blot分别检测多西他赛作用下各组细胞中凋亡相关蛋白Bax和Bcl-2的表达情况以及PI3K/AKT 信号转导通路的活化情况。结果 在5~40 μg/mL浓度范围内,随着多西他赛作用浓度的增大,MCF-7细胞中Cav-1的蛋白表达量逐渐增加。不同浓度多西他赛对MCF-7细胞的增殖均有明显的抑制作用;在同一浓度多西他赛作用下,转染Cav-1组细胞的增殖抑制率明显高于对照组和空载体组(P<0.01)。与对照组和空载体组相比,20 μg/mL多西他赛作用后转染组细胞中Bax的表达升高(P<0.01),而Bcl-2的表达降低(P<0.01),并且磷酸化AKT (p-AKT)蛋白的表达水平下降(P<0.01),而对照组和空载体组之间Bax、Bcl-2以及p-AKT蛋白的表达则无明显差异(P>0.05)。结论 多西他赛可以通过促进Cav-1的表达影响PI3K/AKT 信号转导通路,进而调节凋亡相关蛋白的表达抑制MCF-7 细胞的增殖。
关键词:  Cav-1  多西他赛  乳腺癌细胞  细胞增殖  基因治疗
DOI:10.11724/jdmu.2017.04.02
分类号:R737.9
基金项目:基金项目:国家自然科学基金项目(81302310)
Effect and potential mechanism of Cav-1 in Docetaxel inhibiting breast cancer MCF-7 cell proliferation
LI Ying1, YIN Liangwei2, LIU Jiwei1, LIU Peng2
1.Department of Oncology, the First Affiliated Hospital of Dalian Medical University, Dalian 116011, China;2.Department of Oncology, Dalian Municipal Central Hospital Affiliated of Dalian Medical Universty, Dalian 116021, China
Abstract:
Objective To investigate the effect and potential mechanism of Cav-1 (Cav-1) on the proliferation inhibiting of breast cancer MCF-7 cell by Docetaxel. Methods The transfection group was established by stable transfection of pcDNA3.1-Cav-1 into MCF-7 cells, while the vector group (pcDNA3.1 vector transfected) and control group (non-transfection MCF-7 cells) were used as control. The Cav-1 expression of MCF-7 cells treated by Docetaxel was detected by Real-time PCR and Western-blot. CCK-8 assay was used to analyze the cell proliferation. The expression of Bax and Bcl-2 proteins and the activation of PI3K/AKT signal pathway were examined by Western-blot. Results The expression of Cav-1 in MCF-7 cells was gradually enhanced with the increasing of Docetaxel concentration in the range of 5-40 μg/mL.The inhibitory rate of cell proliferation in Cav-1 transfection group was significantly higher than that of the control groups after Docetaxel treatment (P<0.01). Compared with the control groups, Bax expression increased and Bcl-2 and p-AKT expression decreased in Cav-1 transfection group (P<0.01), while there was no significant difference between the two control groups (P>0.05). Conslusion Docetaxel might inhibit the proliferation of MCF-7 cells by promoting the Cav-1 expression, which can regulate the apoptosis-related protein expression and suppress the activation of PI3K/AKT signaling pathway.
Key words:  Cav-1  Docetaxel  breast cancer cells  cell proliferation  gene therapy